Figure 4.

Additional GIT1 attenuated sFlt-1-induced preeclampsia phenotype in WT mice. (A) Systolic blood pressure (B) Diastolic blood pressure. The tests were started at day 2(-2) before administration of sFlt-1 and finished at day 6(6) after administration of sFlt-1, day 0(0) was the day administrated with sFlt-1, day 1 was the day administrated with GIT1. (C) Urinary Albumin Excretion (D) Creatinine Clearance. The tests were done at day 6 after administration of sFlt-1. Vehicle group was WT mice treated with sFlt-1, GIT1 group was WT mice treated with sFlt-1 and GIT1. N = 6 mice in each experimental group. P < 0.05,**P < 0.01 vs. Vehicle mice.